RCM
BTTX

Radcliffe Capital Management’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Radcliffe Capital Management’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,668
Closed -$1M – 1078
2021
Q3 		$1M Sell
100,668
-99,332
-50% -$991K 0.03% 678
2021
Q2 		$1.98M Buy
+200,000
New +$1.98M 0.06% 494